[dee]

PSYCHIATRIC RESEARCH STUDY
FOR CANCER PATIENTS

The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center is conducting a study designed to measure the effectiveness of the novel psychoactive medication psilocybin on the reduction of anxiety, depression, and physical pain.

In order to participate, you must:

• Have stage IV cancer and anxiety.
• Be between the ages of 18 - 70.
• Not have cancer that affects the central nervous system or brain function.
• Have no history of major psychiatric disorder.
• Have no kidney disease, abnormal liver functions, diabetes, epilepsy, or cardiovascular disease, including untreated hypertension.
• Not be taking insulin, oral hypoglycemic, anti-seizure, or heart medications.

If you qualify and choose to participate, you will

• Spend two nights at the hospital for medication administration.
• Receive psilocybin, a novel psychoactive medication.
• Get an MRI scan of the brain if you have not had one recently.

For further information call:
Charles S. Grob, MD or the study nurse
at 310-222-3175








1124 W. Carson Street
Torrance, CA 90502-2052
www.rei.edu